Study "Hepatitis C - assessment of prevalence (and risk behaviours) in an injected drug use environment"
The study "Hepatitis C - Evaluation of the prevalence (and risk behaviours) in an injected drug use environment" was approved by the Ethics Committee of the Northern Lisbon Hospital Centre (CHLN), the Lisbon Academic Studies Centre (CAML) and the National Commission for Data Protection, under the coordination of Professor Francisco Antunes, from the Institute of Environmental Health - Faculty of Medicine, University of Lisbon.
On 20 and 31 October, the training of the first group of study researchers took place in the espaço Intendente of the Group of Activists undergoing Treatment (GAT).
All information in the November Newsletter of the GAT.